Home / Inspections / 1121802

FDA Inspection 1121802 — Bristol-Myers Squibb Manufacturing Company Unlimited Company

Bristol-Myers Squibb Manufacturing Company Unlimited Company — FEI 2623458

The FDA completed an inspection of Bristol-Myers Squibb Manufacturing Company Unlimited Company on February 14, 2020 in Humacao, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 14, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Humacao, PR (United States)

Facility

Other inspections at this facility

  • 1051117 (VAI Fri Apr 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 993014 (VAI Fri Nov 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 956226 (NAI Wed Dec 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 866747 (VAI Thu Feb 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 768189 (NAI Thu Feb 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources